Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05827614
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-03-27
Brief Title:
Study of the CHK1 Inhibitor BBI-355 an EcDNA-directed Therapy ecDTx in Subjects with Tumors with Oncogene Amplifications
Sponsor:
Boundless Bio
Organization:
Boundless Bio
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-small Cell Lung Cancer |
| Non-Small Cell Lung Adenocarcinoma |
| Non-Small Cell Squamous Lung Cancer |
| Head and Neck Squamous Cell Carcinoma |
| Esophageal Cancer |
| Gastric Cancer |
| Breast Cancer |
| Bladder Cancer |
| Ovarian Cancer |
| Endometrial Cancer |
| Liposarcoma |